Why Are Chronic Kidney Disease Patients Anorexic and What Can Be Done About It?

Seminars in Nephrology

Volumn 29, Issue 1, 2009, Pages 15-23

  Chazot, Charles ^a  

^a Centre de Rein Artificiel de Tassin   (France)

Author keywords

appetite; chronic kidney disease (CKD); Food intake; hemodialysis; leptin; malnutrition; peritoneal dialysis; serotonin

Indexed keywords

AGOUTI RELATED PROTEIN; APPETITE STIMULANT; CHOLECYSTOKININ; CYTOKINE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; LEPTIN; MEGESTROL ACETATE; MELANOCORTIN RECEPTOR; NEUROPEPTIDE Y; NEUROTRANSMITTER; PEPTIDE YY; SEROTONIN; TRYPTOPHAN;

ADIPOSE TISSUE; ANAMNESIS; ANOREXIA; ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COUNSELING; DIALYSIS; ECHOGRAPHY; FOOD INTAKE; GASTROINTESTINAL TRACT; GLOMERULUS FILTRATION RATE; HUMAN; LABORATORY TEST; NONHUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL; TREATMENT OUTCOME; UREMIA;

AGED, 80 AND OVER; ANOREXIA; APPETITE; APPETITE STIMULANTS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS;

EID: 58049206678     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2008.10.003     Document Type: Article

References (71)

1. Ikizler T.A., Greene J.H., Wingard R.L., Parker R.A., and Hakim R.M. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6 (1995) 1386-1391
2. Burrowes J.D., Larive B., Chertow G.M., Cockram D.B., Dwyer J.T., Greene T., et al. Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study. Nephrol Dial Transplant 20 (2005) 2765-2774. http://www.ingentaconnect.com Available from: www.ingentaconnect.com
3. Carrero J.J., Qureshi A.R., Axelsson J., Avesani C.M., Suliman M.E., Kato S., et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr 85 (2007) 695-701
4. Kalantar-Zadeh K. Causes and consequences of the reverse epidemiology of body mass index in dialysis patients. J Ren Nutr 15 (2005) 142-147
5. Lopes A.A., Elder S.J., Ginsberg N., Andreucci V.E., Cruz J.M., Fukuhara S., et al. Lack of appetite in haemodialysis patients-associations with patient characteristics, indicators of nutritional status and outcomes in the international DOPPS. Nephrol Dial Transplant 22 (2007) 3538-3546
6. Sutton D., Higgins B., and Stevens J.M. Continuous ambulatory peritoneal dialysis patients are unable to increase dietary intake to recommended levels. J Ren Nutr 17 (2007) 329-335
7. Mehrotra R., and Kopple J.D. Protein and energy nutrition among adult patients treated with chronic peritoneal dialysis. Adv Ren Replace Ther 10 (2003) 194-212
8. Aguilera A., Codoceo R., Bajo M.A., Iglesias P., Diez J.J., Barril G., et al. Eating behavior disorders in uremia: a question of balance in appetite regulation. Semin Dial 17 (2004) 44-52
9. Aguilera A., Sanchez-Tomero J.A., and Selgas R. Brain activation in uremic anorexia. J Ren Nutr 17 (2007) 57-61
10. Korner J., and Leibel R.L. To eat or not to eat-how the gut talks to the brain. N Engl J Med 349 (2003) 926-928
11. Nardone G., Rocco A., Fiorillo M., Del Pezzo M., Autiero G., Cuomo R., et al. Gastroduodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure. Helicobacter 10 (2005) 53-58
12. De Schoenmakere G., Vanholder R., Rottey S., Duym P., and Lameire N. Relationship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients. Nephrol Dial Transplant 16 (2001) 1850-1855
13. Fernstrom A., Hylander B., Gryback P., Jacobsson H., and Hellstrom P.M. Gastric emptying and electrogastrography in patients on CAPD. Perit Dial Int 19 (1999) 429-437
14. Simenhoff M.L., Dunn S.R., Zollner G.P., Fitzpatrick M.E., Emery S.M., Sandine W.E., et al. Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus. Miner Electrolyte Metab 22 (1996) 92-96
15. Anderstam B., Mamoun A.H., Sodersten P., and Bergstrom J. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am Soc Nephrol 7 (1996) 2453-2460
16. Kopple J.D., Greene T., Chumlea W.C., Hollinger D., Maroni B.J., Merrill D., et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int 57 (2000) 1688-1703
17. Chazot C., Charra B., Vo Van C., Jean G., Vanel T., Calemard E., et al. The Janus-faced aspect of 'dry weight.'. Nephrol Dial Transplant 14 (1999) 121-124
18. Mehrotra R., Berman N., Alistwani A., and Kopple J.D. Improvement of nutritional status after initiation of maintenance hemodialysis. Am J Kidney Dis 40 (2002) 133-142
19. Burrowes J.D., Larive B., Cockram D.B., Dwyer J., Kusek J.W., McLeroy S., et al. Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results from the HEMO study. J Ren Nutr 13 (2003) 191-198
20. Chauveau P., Grigaut E., Kolko A., Wolff P., Combe C., and Aparicio M. Evaluation of nutritional status in patients with kidney disease: usefulness of dietary recall. J Ren Nutr 17 (2007) 88-92
21. Galland R., Traeger J., Arkouche W., Delawari E., and Fouque D. Short daily hemodialysis and nutritional status. Am J Kidney Dis 37 (2001) S95-S98
22. Chauveau P., Naret C., Puget J., Zins B., and Poignet J.L. Adequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of a new on-line urea monitor. Nephrol Dial Transplant 11 (1996) 1568-1573
23. Stenvinkel P., and Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 15 (2002) 329-337
24. Kalantar-Zadeh K., Block G., McAllister C.J., Humphreys M.H., and Kopple J.D. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 80 (2004) 299-307
25. Espat N.J., Copeland E.M., and Moldawer L.L. Tumor necrosis factor and cachexia: a current perspective. Surg Oncol 3 (1994) 255-262
26. McCarthy D.O. Tumor necrosis factor alpha and interleukin-6 have differential effects on food intake and gastric emptying in fasted rats. Res Nurs Health 23 (2000) 222-228
27. Avesani C.M., Carrero J.J., Axelsson J., Qureshi A.R., Lindholm B., and Stenvinkel P. Inflammation and wasting in chronic kidney disease: partners in crime. Kidney Int 70 (2006) S8-S13
28. Siassi F., Wang M., Kopple J.D., and Swendseid M.E. Brain serotonin turnover in chronically uremic rats. Am J Physiol 232 (1977) E526-E528
29. Bergstrom J., Alvestrand A., and Furst P. Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int 38 (1990) 108-114
30. Kopple J.D., and Swendseid M.E. Protein and amino acid metabolism in uremic patients undergoing maintenance hemodialysis. Kidney Int Suppl 7 (1975) 64-72
31. Sharma K., Considine R.V., Michael B., Dunn S.R., Weisberg L.S., Kurnik B.R., et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51 (1997) 1980-1985
32. Cheung W., Yu P.X., Little B.M., Cone R.D., Marks D.L., and Mak R.H. Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 115 (2005) 1659-1665
33. Marks D.L., and Cone R.D. Central melanocortins and the regulation of weight during acute and chronic disease. Recent Prog Horm Res 56 (2001) 359-375
34. Aguilera A., Cirugeda A., Amair R., Sansone G., Alegre L., Codoceo R., et al. Ghrelin plasma levels and appetite in peritoneal dialysis patients. Adv Perit Dial 20 (2004) 194-199
35. Iglesias P., Diez J.J., Fernandez-Reyes M.J., Codoceo R., Alvarez-Fidalgo P., Bajo M.A., et al. Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis. Clin Endocrinol (Oxf) 64 (2006) 68-73
36. Yoshimoto A., Mori K., Sugawara A., Mukoyama M., Yahata K., Suganami T., et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 13 (2002) 2748-2752
37. Odar-Cederlof I., Ericsson F., Theodorsson E., and Kjellstrand C.M. Is neuropeptide Y a contributor to volume-induced hypertension?. Am J Kidney Dis 31 (1998) 803-808
38. Zoccali C., Mallamaci F., Tripepi G., Benedetto F.A., Parlongo S., Cutrupi S., et al. Prospective study of neuropeptide Y as an adverse cardiovascular risk factor in end-stage renal disease. J Am Soc Nephrol 14 (2003) 2611-2617
39. Wright M., Woodrow G., O'Brien S., King N., Dye L., Blundell J., et al. Disturbed appetite patterns and nutrient intake in peritoneal dialysis patients. Perit Dial Int 23 (2003) 550-556
40. Canaud B., Bouloux C., Rivory J.P., Taib J., Garred L.J., Florence P., et al. Erythropoietin-induced changes in protein nutrition: quantitative assessment by urea kinetic modeling analysis. Blood Purif 8 (1990) 301-308
41. Kokot F., Wiecek A., Mesjasz J., Adamczak M., and Spiechowicz U. Influence of long-term recombinant human erythropoietin (rHuEpo) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients. Nephrol Dial Transplant 13 (1998) 1200-1205
42. Fouque D., Vennegoor M., ter Wee P., Wanner C., Basci A., Canaud B., et al. EBPG guideline on nutrition. Nephrol Dial Transplant 22 (2007) ii45-ii87
43. Leon J.B., Albert J.M., Gilchrist G., Kushner I., Lerner E., Mach S., et al. Improving albumin levels among hemodialysis patients: a community-based randomized controlled trial. Am J Kidney Dis 48 (2006) 28-36
44. Johansen K.L. Exercise in the end-stage renal disease population. J Am Soc Nephrol 18 (2007) 1845-1854. http://www.jasn.asnjournals.org Available from: www.jasn.asnjournals.org
45. Frey S., Mir A.R., and Lucas M. Visceral protein status and caloric intake in exercising versus nonexercising individuals with end-stage renal disease. J Ren Nutr 9 (1999) 71-77
46. Kopple J.D., Wang H., Casaburi R., Fournier M., Lewis M.I., Taylor W., et al. Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle. J Am Soc Nephrol 18 (2007) 2975-2986. http://www.jasn.asnjournals.org Available from: www.jasn.asnjournals.org
47. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 35 (2000) S1-S140
48. Rocco M.V., Dwyer J.T., Larive B., Greene T., Cockram D.B., Chumlea W.C., et al. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO Study. Kidney Int 65 (2004) 2321-2334
49. Chazot C., Vo V.C., Blanc C., Hurot J.M., Jean G., Vanel T., et al. Stability of nutritional parameters during a 5-year follow-up in patients treated with sequential long-hour hemodialysis. Hemodial Int 10 (2006) 389-393
50. Galland R., Traeger J., Arkouche W., Cleaud C., Delawari E., and Fouque D. Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int 60 (2001) 1555-1560
51. Alloatti S., Molino A., Manes M., Bonfant G., and Pellu V. Long nocturnal dialysis. Blood Purif 20 (2002) 525-530
52. Charra B., Laurent G., Chazot C., Jean G., Terrat J.C., and Vanel T. Hemodialysis trends in time, 1989 to 1998, independent of dose and outcome. Am J Kidney Dis 32 (1998) S63-S70
53. Locatelli F., Mastrangelo F., Redaelli B., Ronco C., Marcelli D., La Greca G., et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 50 (1996) 1293-1302
54. Savica V., Ciolino F., Monardo P., Mallamace A., Savica R., Santoro D., et al. Nutritional status in hemodialysis patients: options for on-line convective treatment. J Ren Nutr 16 (2006) 237-240
55. Schiffl H. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res 12 (2007) 26-33
56. Wizemann V., Lotz C., Techert F., and Uthoff S. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 15 (2000) 43-48
57. Davies S.J., Phillips L., Griffiths A.M., Naish P.F., and Russell G.I. Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients. Kidney Int 57 (2000) 1743-1754
58. Maltoni M., Nanni O., Scarpi E., Rossi D., Serra P., and Amadori D. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol 12 (2001) 289-300
59. Yeh S.S., Wu S.Y., Levine D.M., Parker T.S., Olson J.S., Stevens M.R., et al. The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients. J Gerontol A Biol Sci Med Sci 56 (2001) M48-M54
60. Batterham M.J., and Garsia R. A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss. Int J Androl 24 (2001) 232-240
61. Von Roenn J.H., Armstrong D., Kotler D.P., Cohn D.L., Klimas N.G., Tchekmedyian N.S., et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 121 (1994) 393-399
62. Wermers R.A., Hurley D.L., and Kearns A.E. Osteoporosis associated with megestrol acetate. Mayo Clin Proc 79 (2004) 1557-1571
63. Mantovani G., Maccio A., Lai P., Massa E., Ghiani M., and Santona M.C. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Semin Oncol 25 (1998) 45-52
64. Williams J.L., Perius M., Humble L., Sigler D., Urbanes A., and Shapiro H.S. Effect of megestrol acetate on the nutritional status of malnourished hemodialysis patients. [abstract]. J Ren Nutr 7 (1997) 231
65. Boccanfuso J.A., Hutton M., and McAllister B. The effects of megestrol acetate on nutritional parameters in a dialysis population. J Ren Nutr 10 (2000) 36-43
66. Costero O., Bajo M.A., del Peso G., Gil F., Aguilera A., Ros S., et al. Treatment of anorexia and malnutrition in peritoneal dialysis patients with megestrol acetate. Adv Perit Dial 20 (2004) 209-212
67. Lien Y.H., and Ruffenach S.J. Low dose megestrol increases serum albumin in malnourished dialysis patients. Int J Artif Organs 19 (1996) 147-150
68. Burrowes J.D., Bluestone P.A., Wang J., and Pierson Jr. R.N. The effects of moderate doses of megestrol acetate on nutritional status and body composition in a hemodialysis patient. J Ren Nutr 9 (1999) 89-94
69. Rammohan M., Kalantar-Zadeh K., Liang A., and Ghossein C. Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. J Ren Nutr 15 (2005) 345-355
70. Hiroshige K., Sonta T., Suda T., Kanegae K., and Ohtani A. Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant 16 (2001) 1856-1862
71. Cano N., Labastie-Coeyrehourq J., Lacombe P., Stroumza P., di Costanzo-Dufetel J., Durbec J.P., et al. Predialytic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients. Am J Clin Nutr 52 (1990) 726-730